Stephen Spurgeon, MD
Internal Medicine · Portland, ORNPI 1194730606
Payments from drug & device makers
Across 516 payments — averaging $16,586 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Beigene, Ltd.$5.5M
- Beone Medicines Ltd.$433K
- Genentech, Inc.$398K
- E.r. Squibb & Sons, L.L.C.$395K
- Bristol Myers Squibb$394K
- Incyte Corporation$350K
- plus $1M from 18 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Beigene, Ltd. | 264 | $5,539,700 |
| Beone Medicines Ltd. | 23 | $433,420 |
| Genentech, Inc. | 26 | $397,858 |
| E.r. Squibb & Sons, L.L.C. | 6 | $395,435 |
| Bristol Myers Squibb | 5 | $394,135 |
| Incyte Corporation | 10 | $350,130 |
| Merck | 3 | $281,199 |
| Acerta Pharma LLC | 22 | $273,669 |
| Janssen Research & Development, LLC | 42 | $221,833 |
| Gilead | 26 | $131,008 |
| AstraZeneca | 28 | $66,801 |
| AbbVie | 8 | $41,529 |
| TG Therapeutics, Inc. | 12 | $12,266 |
| Janssen Scientific Affairs, LLC | 12 | $6,265 |
| Pharmacyclics LLC, An Abbvie Company | 6 | $3,091 |
| Genentech USA, Inc. | 6 | $2,719 |
| Innate Pharma, Inc | 1 | $2,400 |
| Beigene USA, Inc. | 1 | $2,250 |
| Karyopharm Therapeutics Inc. | 1 | $1,938 |
| ADC Therapeutics America, Inc. | 4 | $343 |
| Genmab U.S., Inc. | 5 | $342 |
| Beone Medicines USA, Inc. | 3 | $183 |
| Pfizer | 1 | $84 |
| Novartis | 1 | $30 |
How this compares
$8,558,629 in reported general payments places this provider in the 95th percentile of 1,363 internal medicine providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Portland
- James BergtholdPortland$4.7M
- Stephen FortmannPortland$3.3M
- Maryann ConradPortland$2.7M
- Jennifer SaultzPortland$1.9M
- Brian BattaliaPortland$524K
- Natasha EdwinPortland$365K
- Michael AzorrPortland$288K
- Charles ElderPortland$245K
- Jessica CastlePortland$153K
- Pranav ChandrashekarPortland$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.